HIMSS 25 was a pivotal event for Velox, demonstrating our commitment to transforming clinical data operations. Our leadership team, including Founder and CEO Michael Klotz, Co-Founder and Chief Medical Officer Dr. Michael Barr, and Chief Commercial Officer Will Stabler, emphasized our dedication to advancing healthcare technology.

We engaged in productive meetings, gathering valuable insights into our customers’ and collaborators’  evolving needs and market opportunities. These discussions validated our road map, reinforced our internal alignment, and laid the foundation for future partnerships to ensure Velox remains at the forefront of addressing clinical data exchange challenges.

A standout event was our co-presentation with Charlie Harp, CEO of Clinical Architecture, on “Quality & Quantity: Essential Frameworks for Clinical Data Operations for Payers.” This session emphasized the importance of strategic data acquisition and purposeful data improvement linked to specific payer and provider use cases.

The need is clear, and our message at HIMSS 25 resonated with clients, collaborators, and investors: the time is now for the unique solutions Velox, with our partners, is bringing to market. Our capabilities to find and refine clinical data to support multiple use cases—such as Risk Adjustment, Quality Reporting, Fraud-Waste Abuse, and Care Management—meet a critical need not addressed by existing technology vendors.

As we move forward, Velox remains dedicated to leveraging our expertise and partnerships to address the complexities of clinical data operations. The insights gained from HIMSS 25 will catalyze our continued growth and innovation.